Skip to main content
Newspaper/Magazine Article

There is a vulnerable group we must not leave behind in our response to COVID-19: people who are dependent on illicit drugs.

Guirguis A. The Pharmaceutical Journal. 2020;304(7937). 

Save
Print
May 13, 2020
Guirguis A. The Pharmaceutical Journal. 2020;304(7937).

Users of illicit substances are vulnerable to a variety of health concerns. This article discusses how the COVID-19 pandemic places illicit drug users at increased risk for COVID-19 due to their predisposition to infection and social contact; how disruptions to illicit drug supply chains increase risk for overdose due to drug substitution and; the impact of missing out on drug treatment services. The piece highlights the role of pharmacists in keeping this marginalized patient population safe.

Save
Print
Cite
Citation

Guirguis A. The Pharmaceutical Journal. 2020;304(7937). 

Related Resources